Quick Answer
CROSS COUNTRY HEALTHCARE INC reported Operating Income Loss of -$84.41 million for the year ending 2025.
- CROSS COUNTRY HEALTHCARE INC showed a decrease of -400.5% in Operating Income Loss from 2024 to 2025.
- This data is from CROSS COUNTRY HEALTHCARE INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $3.36 million | Q3 2010: $2.94 million | Q1 2011: $1.06 million | Q2 2011: $2.60 million | Q3 2011: $4.16 million | Q1 2012: -$914.0 thousand | Q2 2012: -$21.38 million | Q3 2012: -$1.25 million | Q1 2013: -$199.0 thousand | Q2 2013: -$1.63 million | Q3 2013: $914.0 thousand | Q1 2014: -$1.49 million | Q2 2014: -$1.87 million | Q3 2014: $1.76 million | Q1 2015: $3.72 million | Q2 2015: $4.32 million | Q3 2015: $6.87 million | Q1 2016: $5.17 million | Q2 2016: -$17.02 million | Q3 2016: $9.33 million | Q1 2017: $3.26 million | Q2 2017: $6.45 million | Q3 2017: $8.37 million | Q1 2018: $4.25 million | Q2 2018: $4.34 million | Q3 2018: $2.65 million | Q1 2019: -$2.69 million | Q2 2019: -$15.10 million | Q3 2019: $119.0 thousand | Q1 2020: -$754.0 thousand | Q2 2020: -$13.69 million | Q3 2020: -$381.0 thousand | Q1 2021: $20.99 million | Q2 2021: $15.90 million | Q3 2021: $26.45 million | Q1 2022: $90.63 million | Q2 2022: $78.84 million | Q3 2022: $52.18 million | Q1 2023: $43.80 million | Q2 2023: $35.19 million | Q3 2023: $20.30 million | Q1 2024: $2.92 million | Q2 2024: -$19.21 million | Q3 2024: $2.85 million | Q1 2025: -$977.0 thousand | Q2 2025: -$5.86 million | Q3 2025: -$5.97 million.
- Over the full 17 years of available data (2009 to 2025), CROSS COUNTRY HEALTHCARE INC's Operating Income Loss has declined by 576.9%.
- Historical annual values: Fiscal year 2025: -$84.41 million | Fiscal year 2024: -$16.87 million | Fiscal year 2023: $112.71 million | Fiscal year 2022: $269.88 million | Fiscal year 2021: $139.30 million | Fiscal year 2020: -$9.16 million | Fiscal year 2019: -$15.71 million | Fiscal year 2018: -$12.88 million | Fiscal year 2017: $11.75 million | Fiscal year 2016: $6.18 million | Fiscal year 2015: $20.57 million | Fiscal year 2014: -$10.47 million | Fiscal year 2013: -$8.02 million | Fiscal year 2012: -$24.52 million | Fiscal year 2011: $5.91 million | Fiscal year 2010: -$3.81 million | Fiscal year 2009: $17.70 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: